Regencell Bioscience/RGC

$5.55

6.32%
-
1D1W1MYTD1YMAX

About Regencell Bioscience

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Ticker

RGC

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

-

Employees

12

Headquarters

Null, Hong Kong

RGC Metrics

BasicAdvanced
$67.93M
Market cap
-
P/E ratio
-$0.59
EPS
-
Beta
-
Dividend rate
$67.93M
$31.30
$3.16
3.64K
28.463
-82.73%
-113.96%
-113.11%
3.98
3.98
-450.33%

RGC Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0% profit margin
QuarterlyAnnual
Q4 22
QoQ growth
Revenue
$0
-
Net income
$-3.8M
8.57%
Profit margin
0%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Regencell Bioscience stock?

Regencell Bioscience (RGC) has a market cap of $67.93M as of April 20, 2024.

What is the P/E ratio for Regencell Bioscience stock?

The price to earnings (P/E) ratio for Regencell Bioscience (RGC) stock is 0 as of April 20, 2024.

Does Regencell Bioscience stock pay dividends?

No, Regencell Bioscience (RGC) stock does not pay dividends to its shareholders as of April 20, 2024.

When is the next Regencell Bioscience dividend payment date?

Regencell Bioscience (RGC) stock does not pay dividends to its shareholders.

What is the beta indicator for Regencell Bioscience?

Regencell Bioscience (RGC) does not currently have a Beta indicator.

What is the Regencell Bioscience stock price target?

The target price for Regencell Bioscience (RGC) stock is $, which is 100% below the current price of $5.55. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Regencell Bioscience stock

Buy or sell Regencell Bioscience stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing